Company
GRIN Therapeutics, Inc.
GRIN Therapeutics, Inc. has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Radiprodil | Phase 3 | GRIN-related Neurodevelopmental Disorder |
Latest
No recent events.
Follow GRIN Therapeutics, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.